Skip to Content

Join the 'Melanoma - Metastatic' group to help and get support from people like you.

Melanoma - Metastatic News

Many College Women Ignore Indoor Tanning's Risks

Posted 5 days ago by Drugs.com

FRIDAY, Jan. 13, 2017 – Despite the known dangers, many white female college students continue to tan indoors, a new study finds. Indoor tanning can lead to premature skin aging and skin cancers, including potentially deadly melanoma. It's particularly risky for younger people and frequent users, according to the U.S. Centers for Disease Control and Prevention. For this study, researchers at Indiana University surveyed 629 white female undergraduate and graduate students. Just about all of the young women knew that tanning can cause premature skin aging and skin cancer. Moreover, almost 80 percent did not believe that indoor tanning is safe or any safer than outdoor tanning. Still, about seven out of 10 said they like to get a tan even though they know tanning may harm their skin. Nearly 84 percent said tanning makes them feel more attractive. Those more likely to use tanning booths or ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Sunscreen, Melanoma - Metastatic, Squamous Cell Carcinoma, Prevention of Sunburn, History - Skin Cancer, Coppertone, Deeptan

Melanoma Rates Rise in Some States, Fall in Others

Posted 29 Dec 2016 by Drugs.com

THURSDAY, Dec. 29, 2016 – Rates of melanoma cases and deaths are either rising or falling, depending on which state you might be living in, a new study finds. Between 2003 and 2013, Americans living in the Midwest and South, especially, tended to have rising rates of both the incidence of melanoma and deaths related to the skin cancer, researchers found. "The Northeast, specifically New England, is the only U.S. geographic region in which most states experienced a reduction in both death and incidence rates," wrote a team led by Dr. Robert Dellavalle of the Denver Veterans Affairs Medical Center and the University of Colorado School of Medicine. One skin cancer specialist who reviewed the findings said they highlight the need for better sun-safety education. "As a medical community, we still have work to do in educating the public – especially in certain states – on the importance of ... Read more

Related support groups: Melanoma, Melanoma - Metastatic

U.S. Melanoma Rate Is Rising, Study Finds

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – More Americans are developing the potentially deadly skin cancer known as melanoma than in the past, new research shows. In 2016, one out of every 54 Americans was expected to develop a potentially lethal, invasive melanoma over their lifetime – up from the one in 58 estimate when the same tally was performed in 2009. Overall, an estimated 76,380 Americans will be diagnosed with melanoma in 2016, said a team led by Dr. Alex Glazer of the National Society for Cutaneous Medicine in New York City. "The overall burden of disease for melanoma is increasing," Glazer's team reported in a study published online Dec. 21 in JAMA Dermatology. Skin cancers are by far the most common cancer for Americans. Most are easily treated and removed, but melanomas can be much more serious. According to the American Cancer Society, "melanoma accounts for only about 1 percent of ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Diagnosis and Investigation, History - Skin Cancer

A Little Training Helps Couples Ease Into Skin Cancer Checks

Posted 14 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 14, 2016 – Skin cancer checks between couples don't have to be a puzzle – or embarrassing, a new study shows. Over time, and with some training on spotting troublesome moles and potential skin cancer lesions, partners gained confidence and overcame their inhibitions about the checks, the researchers said. Embarrassment was especially an issue for women, said the team led by Dr. June Robinson, a professor of dermatology at Northwestern University Feinberg School of Medicine in Chicago. "These aren't parts of the body that most females like to have examined by their male partner, but at some point, they realized they're just looking at the moles, not the cellulite," Robinson said in a university news release. "We found that as long as the [health] benefit is strong enough, it overcomes whatever potential embarrassment there might be between the partners," she said. One ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Diagnosis and Investigation, History - Skin Cancer

Keeping Minors From Tanning Beds Would Save Thousands of Lives, Study Says

Posted 6 Dec 2016 by Drugs.com

TUESDAY, Dec. 6, 2016 – Restricting people younger than 18 from indoor tanning could prevent thousands of skin cancers and deaths in the United States, according to a new study. An age limitation would also save the country hundreds of millions of dollars in skin cancer treatment costs, researchers found. "This research concretely demonstrates the potential health benefits of an under-18 age restriction for indoor tanning," said Dr. Abel Torres, president of the American Academy of Dermatology Association. People who engage in indoor tanning are exposed to ultraviolet radiation, a major risk factor for skin cancer. Using indoor tanning before age 35 increases the risk of melanoma – the deadliest type of skin cancer – with each use, the researchers said. Last year, the U.S. Food and Drug Administration proposed a ban on indoor tanning by people younger than 18. At least a dozen states ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Prevention of Sunburn, History - Skin Cancer

Could White Wine Boost Your Melanoma Risk?

Posted 1 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – A new study raises the possibility that people who enjoy a glass of white wine every day may face a slightly elevated risk of melanoma. Total alcohol intake was associated with a 14 percent higher risk of melanoma per drink per day, researchers found. But, when they looked at the type of alcohol consumed, white wine emerged as the potential culprit. Each drink per day of white wine was associated with a 13 percent higher risk of melanoma, the researchers said. "Per drink" risk was based on 12.8 grams of alcohol – the median amount of alcohol in a beer, a glass of wine or a shot of spirits. Beer, red wine and liquor did not significantly affect melanoma risk, the study authors added. The study does not prove that white wine causes this deadly skin cancer. It merely shows an association, though one worth exploring, the researchers said. "We are just adding one ... Read more

Related support groups: Cancer, Breast Cancer, Alcohol Dependence, Colorectal Cancer, Basal Cell Carcinoma, Melanoma, Skin Cancer, Alcoholism, Hangover, Melanoma - Metastatic, Squamous Cell Carcinoma, Head and Neck Cancer, Breast Cancer, Prevention, History - Skin Cancer, Acute Alcohol Intoxication

8 of 10 Texas Salons Heed Ban on Indoor Tanning for Minors

Posted 25 Nov 2016 by Drugs.com

FRIDAY, Nov. 25, 2016 – Most indoor tanning salons in Texas comply with a law banning customers younger than 18, a new study found. Females posing as 17-year-olds called 829 tanning businesses statewide. Workers at 81 percent of the salons told the caller they could not use indoor tanning if they were 17, even with a parent's permission. "This level of compliance with the under-18 ban enacted by the Texas Legislature in 2013 underscores the importance of this approach as a strategy for skin cancer prevention," study lead author Mary Tripp said. Tripp is an instructor in behavioral science at the University of Texas MD Anderson Cancer Center. Despite high compliance with the under-18 ban, 83 percent of salons said clients could tan every day, Tripp noted in a university news release. The U.S. Food and Drug Administration recommends no more than three sessions during the first week of ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Prevention of Sunburn, History - Skin Cancer

Can Protein in Common Skin Bacteria Offer Disease Protection?

Posted 23 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 23, 2016 – Our most common skin bacteria may help shield us from some skin diseases, a new study suggests. Swedish researchers report that Propionibacterium acnes secretes a protein called RoxP that protects against bacteria that are believed to contribute to several skin disorders. Specifically, RoxP protects against skin cell damage called oxidative stress caused by reactive oxygen bacteria. UV radiation from the sun is a common cause of oxidative stress on the skin. Oxidative stress is believed to contribute to several skin diseases, including eczema, psoriasis and skin cancer. The protective effect of RoxP is as strong as antioxidants such as vitamins C and E, according to the study published recently in the journal Scientific Reports. "This protein is important for the bacterium's very survival on our skin. The bacterium improves its living environment by secreting ... Read more

Related support groups: Acne, Psoriasis, Eczema, Dermatitis, Rosacea, Contact Dermatitis, Basal Cell Carcinoma, Melanoma, Skin Cancer, Atopic Dermatitis, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer, Minor Skin Conditions, Minor Skin Irritation

'Tailoring' Skin Exams May Boost Melanoma Detection

Posted 10 Nov 2016 by Drugs.com

THURSDAY, Nov. 10, 2016 – Some people at high risk of melanoma may benefit from more "tailored" skin exams, a new study suggests. Melanoma is the least common, but most serious form of skin cancer. It's estimated that about 76,400 Americans will be diagnosed with the disease in 2016, according to the American Cancer Society (ACS). Melanoma can be caught early if suspicious growths on the skin are detected. The new study, researchers said, helps zero in on some groups who may need to start skin exams at a younger age, or do them more often: People with a personal or family history of melanoma; and those with a lot of moles on their skin. The report also gives an idea of which body areas people should monitor with particular attention, according to lead researcher Caroline Watts. She's a research fellow at the Sydney School of Public Health, at the University of Sydney in Australia. But ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, History - Skin Cancer

Powerful Cancer Drugs Linked to Rare Heart Risks

Posted 3 Nov 2016 by Drugs.com

THURSDAY, Nov. 3, 2016 – In rare cases, potent drugs that prompt the immune system to fight cancer may threaten the heart in the process, researchers report. Known as immunotherapy, these medications have transformed cancer treatment in recent years, sending some patients who had few options left into remission. But a report in the Nov. 3 issue of New England Journal of Medicine describes two cases where patients with advanced melanoma died of heart trouble two weeks after receiving their first doses of Opdivo (nivolumab) and Yervoy (ipilimumab). One patient was a 65-year-old woman who died following a rapid heartbeat and organ failure, while the other patient was a 63-year-old man who died after two rounds of sudden cardiac arrest. With a heart attack, blood flow to the heart is blocked and tissue damage occurs, while in the case of sudden cardiac arrest the heart suddenly stops ... Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Melanoma - Metastatic, Opdivo, Keytruda, Yervoy, Tecentriq, Nivolumab, Pembrolizumab, Campath, Lemtrada, Ipilimumab, Alemtuzumab, Atezolizumab

Indoor Tanners Aren't Taking Precautions Against Skin Cancer

Posted 12 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 12, 2016 – Frequent indoor tanners don't protect themselves from the sun and are no more likely to be screened for skin cancer than those who don't tan indoors, a new study suggests. The researchers analyzed data from a 2015 federal government health survey. It included more than 10,200 white adults aged 18 to 60 with no history of skin cancer. Of those, 7 percent said they had tanned indoors within the past year; 3.6 percent had done so one to nine times, and 3.4 percent had done it 10 times or more, the findings showed. Frequent indoor tanning was associated with less use of sunscreen, sun-protective clothing and shade while outdoors, and with several sunburns in the past year. In addition, frequent indoor tanners aged 18 to 34 were more likely to rarely or never wear sun-protective clothing or to seek shade on a sunny day than those who had never used a tanning bed. ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer

Organ Transplants Linked to Higher Skin Cancer Risk

Posted 21 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 21, 2016 – People who have an organ transplant may be more likely to develop skin cancer, new research suggests. The finding applies to all transplant patients, even those who are nonwhite and dark-skinned, according to Dr. Christina Lee Chung, an associate professor of dermatology at Drexel University in Philadelphia, and colleagues. The researchers said the risk increases over time with ongoing exposure to medications that suppress the immune system to prevent organ rejection. Total-body skin exams should be a routine part of care after transplant surgery, the study authors advised. For the study, the researchers analyzed medical records of 413 organ transplant recipients, 63 percent of whom were not white. The investigators found 19 new skin cancers in 15 of the nonwhite patients. That group included six black patients, five Asians and four Hispanics. Among the ... Read more

Related support groups: Basal Cell Carcinoma, Renal Transplant, Melanoma, Skin Cancer, Melanoma - Metastatic, Organ Transplant - Rejection Prophylaxis, Squamous Cell Carcinoma, Organ Transplant, Kidney Transplant, Graft-versus-host disease, Rejection Prophylaxis, History - Skin Cancer

More Cancer Patients Gaining From Immune-Based Treatments

Posted 20 Sep 2016 by Drugs.com

TUESDAY, Sept. 20, 2016 – A leading cancer group says more Americans are benefiting from immunotherapy – a relatively new treatment approach that helps the immune system target and destroy cancer cells. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," said Dr. Nancy Davidson, president of the American Association for Cancer Research (AACR). The AACR issued the news on immunotherapy as part of its 2016 Cancer Progress Report. As the group explained, more types of cancer are being successfully treated with immunotherapy. This treatment involves adding new cancer-fighting cells to the body or adding new elements, such as antibodies and proteins, to help the immune system fight cancer. In August 2015, one class of immunotherapy drugs – called checkpoint inhibitors – was approved for ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Melanoma, Bladder Cancer, Melanoma - Metastatic, Opdivo, Head and Neck Cancer, Keytruda, Hodgkin's Lymphoma, Tecentriq, Nivolumab, Pembrolizumab, Atezolizumab

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Hydrocodone, Methadone, Percocet, Tramadol, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Tylenol, Chronic Pain, Opana, Ibuprofen, Naproxen

Page 1 2 3 4 5 6 7 8 9 10 Next

Ask a Question

Further Information

Related Condition Support Groups

Melanoma

Related Drug Support Groups

Accutane, isotretinoin, Claravis, Opdivo, Amnesteem, Temodar, Zelboraf, PegIntron, Sotret, view more... Keytruda, Yervoy, vemurafenib, nivolumab, Tafinlar, pembrolizumab, Proleukin, Mekinist, peginterferon alfa-2b, ipilimumab, Cotellic, Myorisan, trametinib, temozolomide, aldesleukin, dabrafenib, Imlygic, talimogene laherparepvec, cobimetinib, Sylatron